Previous Close | 9.89 |
Open | 9.90 |
Bid | 9.77 x 1200 |
Ask | 15.85 x 1000 |
Day's Range | 9.90 - 9.90 |
52 Week Range | 9.77 - 10.02 |
Volume | |
Avg. Volume | 22,313 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Genome sequencing company Human Longevity Inc plans to go public through a merger with Freedom Acquisition I Corp that values the combined company at about $1 billion, the two companies said on Monday. Freedom Acquisition I Corp is a special purpose acquisition company led by former Credit Suisse chief executive Tidjane Thiam, and was listed early last year. A blank-check firm, or a special purpose acquisition company (SPAC), is a listed shell entity that uses the money raised in its IPO to merge with a private company, taking it public in the process.
SAN DIEGO & LONDON, June 20, 2022--Human Longevity, Inc. ("HLI"), built by the pioneers of the human genome sequencing effort, and Freedom Acquisition I Corporation ("Freedom") (NYSE: FACT), a publicly traded special purpose acquisition company, announced today that they have signed a non-binding letter of intent (the "Letter of Intent") for a proposed business combination that would result in HLI becoming a publicly listed company. Upon the closing of the transaction, the combined company would
(Bloomberg) -- Fund management giant Pimco has ended its role as a sponsor of former Credit Suisse Group AG Chief Executive Officer Tidjane Thiam’s fintech SPAC.Most Read from BloombergSwitzerland Imports Russian Gold for First Time Since WarThe World’s Bubbliest Housing Markets Are Flashing Warning SignsLiz Cheney Is Paying the Price in Her Home State for Crossing TrumpStocks Surge After $2 Trillion Wipeout; Bonds Fall: Markets WrapStocks Drop, Bonds Surge With All Eyes on Powell: Markets WrapP